S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
Recent Reports Are A Wake-Up Call For Investors (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Recent Reports Are A Wake-Up Call For Investors (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
Recent Reports Are A Wake-Up Call For Investors (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Recent Reports Are A Wake-Up Call For Investors (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
Recent Reports Are A Wake-Up Call For Investors (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Recent Reports Are A Wake-Up Call For Investors (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
Recent Reports Are A Wake-Up Call For Investors (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Recent Reports Are A Wake-Up Call For Investors (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
New CBOE “special perk” helps traders target income every weekend (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

Cross Country Healthcare (CCRN) Earnings Date, Estimates & Call Transcripts

$20.47
-0.42 (-2.01%)
(As of 12/8/2023 ET)
Compare
Today's Range
$19.86
$20.96
50-Day Range
$17.94
$25.55
52-Week Range
$15.65
$31.82
Volume
271,773 shs
Average Volume
535,718 shs
Market Capitalization
$719.54 million
P/E Ratio
7.26
Dividend Yield
N/A
Price Target
$26.71

Earnings Summary

Upcoming
Earnings Date
Feb. 28Estimated
Actual EPS
(Nov. 1)
$0.39 Missed By -$0.02
Consensus EPS
(Nov. 1)
$0.41
Skip Charts & View Estimated and Actual Earnings Data

CCRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CCRN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cross Country Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$0.74$0.77$0.75$0.70 - $0.80
Q2 20234$0.60$0.78$0.69$0.55 - $0.65
Q3 20234$0.40$0.86$0.62 
Q4 20234$0.26$0.85$0.55 
FY 202315$2.00$3.26$2.60 
Q1 20242$0.31$0.80$0.56 
Q2 20242$0.33$0.84$0.59 
Q3 20242$0.39$0.89$0.64 
Q4 20242$0.40$0.90$0.65 
FY 20248$1.43$3.43 $2.43

CCRN Earnings Date and Information

Cross Country Healthcare last issued its quarterly earnings data on November 1st, 2023. The business services provider reported $0.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.41 by $0.02. The firm had revenue of $442.29 million for the quarter, compared to analyst estimates of $443.90 million. Its revenue for the quarter was down 30.5% compared to the same quarter last year. Cross Country Healthcare has generated $2.82 earnings per share over the last year ($2.82 diluted earnings per share) and currently has a price-to-earnings ratio of 7.3. Earnings for Cross Country Healthcare are expected to decrease by -34.55% in the coming year, from $2.20 to $1.44 per share. Cross Country Healthcare has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off prior year's report dates.

Cross Country Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/28/2024
Estimated)
------- 
11/1/2023Q3 2023$0.41$0.39($0.02)$0.42$443.90 million$442.29 million    
8/2/2023Q2 2023$0.61$0.69+$0.08$0.78$531.70 million$540.70 million    
5/3/2023Q1 2023$0.76$0.84+$0.08$0.87$594.09 million$622.71 million    
2/22/2023Q4 2022$0.90$1.09+$0.19$1.13$594.57 million$628.22 million    
11/2/2022Q3 2022$0.96$1.07+$0.11$1.21$617.93 million$636.10 million
8/3/2022Q2 2022$1.35$1.40+$0.05$1.40$741.57 million$753.56 million
5/4/2022Q1 2022$1.40$1.70+$0.30$1.77$745.54 million$788.70 million    
2/23/2022Q4 2021$1.35$1.40+$0.05$0.73$611.54 million$640.68 million    
11/3/2021Q3 2021$0.35$0.61+$0.26$0.60$316.91 million$374.91 million    
8/4/2021Q2 2021$0.40$0.47+$0.07$0.63$306.21 million$331.83 million  
5/5/2021Q1 2021$0.34$0.58+$0.24$0.63$287.85 million$329.24 million  
2/23/2021Q4 2020$0.09$0.19+$0.10$0.25$191.74 million$215.61 million  












Cross Country Healthcare Earnings - Frequently Asked Questions

When is Cross Country Healthcare's earnings date?

Cross Country Healthcare has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off last year's report dates. Learn more on CCRN's earnings history.

Did Cross Country Healthcare beat their earnings estimates last quarter?

In the previous quarter, Cross Country Healthcare (NASDAQ:CCRN) missed the analysts' consensus estimate of $0.41 by $0.02 with a reported earnings per share (EPS) of $0.39. Learn more on analysts' earnings estimate vs. CCRN's actual earnings.

How can I listen to Cross Country Healthcare's earnings conference call?

The conference call for Cross Country Healthcare's latest earnings report can be listened to online. Listen to Conference Call

How can I read Cross Country Healthcare's conference call transcript?

The conference call transcript for Cross Country Healthcare's latest earnings report can be read online. Read Transcript

How much revenue does Cross Country Healthcare generate each year?

Cross Country Healthcare (NASDAQ:CCRN) has a recorded annual revenue of $2.23 billion.

How much profit does Cross Country Healthcare generate each year?

Cross Country Healthcare (NASDAQ:CCRN) has a recorded net income of $188.46 million. CCRN has generated $2.82 earnings per share over the last four quarters.

What is Cross Country Healthcare's price-to-earnings ratio?

Cross Country Healthcare (NASDAQ:CCRN) has a trailing price-to-earnings ratio of 7.26 and a forward price-to-earnings ratio of 9.30. The price/earnings-to-growth ratio is 0.94.

What is Cross Country Healthcare's EPS forecast for next year?

Cross Country Healthcare's earnings are expected to decrease from $2.20 per share to $1.44 per share in the next year, which is a -34.55% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:CCRN) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -